C-Reactive Protein (C-rP) testing can reveal inflammation and Neprinol has been shown to reduce C-rP levels by an average of 2 points per month. An elevated C-rP is associated with a three-fold increased risk of heart disease based on a clinical trial of 18,000 individuals. Neprinol is a more effective systemic enzyme blend than other options and can reduce arterial plaque, lower LDL cholesterol, and remove scar tissue due to its enteric coating allowing potent absorption.